Ledger.Open graph →
SEC Form D · Amendment · filed March 9, 2015

Resilience Therapeutics, Inc

Offering
$3.0M
Sold
$1.3M
Exemption
Rule 506(b)
Industry
Pharmaceuticals
Location
DUXBURY, MA
Type
—

Rule 506(b): private placement to accredited investors, no public advertising.

People & firms on this filing (11)

Restina M. Meyer · Duxbury, MAExecJason E. Fuller · DUXBURY, MADirectorWilliam M. Cowan · DUXBURY, MADirectorJeffrey R. Sabados · DUXBURY, MAExec · DirectorMichael Stewart · New York, NYDirectorRaymond Whiteman · New York, NYDirectorDouglas Neal · Ann Arbor, MIExec · DirectorJohn Younger · Ann Arbor, MIExec · DirectorElizabeth Resta · Seattle, WADirectorChristine Haller · Seattle, WAExec · DirectorBrianna Griffith · Seattle, WAExec

Public SEC Form D (Reg D) filing. · View issuer on SEC EDGAR ↗